{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:44:01Z","timestamp":1751391841371,"version":"3.40.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","funder":[{"DOI":"10.13039\/501100004035","name":"Deanship of Scientific Research at Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["347\/2019"],"award-info":[{"award-number":["347\/2019"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Pharmaceutical excipients have been shown to influence drug disposition\nthrough modulating transport protein.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>This study assessed the effect of single dose administration of parabens on the pharmacokinetics\n(PK) of digoxin, a probe substrate of p-glycoprotein (p-gp), in vivo. Also, the effect of\nmultiple dosing of parabens on p-gp expression was examined.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Rats were randomized into four groups that received either the vehicle, 25 mg\/ kg verapamil,\n100 mg\/ kg isobutyl paraben, or 100 mg\/ kg 2-ethyl hexyl paraben, which was followed by\ngiving 0.2 mg\/ kg digoxin via oral gavage. Blood samples were collected at different time points,\ndigoxin concentration was measured using LC\/MS-MS, and digoxin PK parameters were estimated.\nAnother set of rats received multiple doses of parabens for 14 days, followed by measuring intestinal\nand hepatic mRNA expression of p-gp using qRT-PCR.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Single dose administration of verapamil significantly increased Cmax (by 60.4 %) and\nAUC0-t (by 61.7 %) of digoxin compared to the control group, while the PK parameters of digoxin\nin rats exposed to parabens were not significantly different from the control. Consistently, the mRNA\nexpression of p-gp in the intestine and liver was not affected by parabens treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>The lack of isobutylparaben and 2-ethylhexyl paraben effect on p-gp may suggest\nthe insignificant interaction of parabens with p-gp drug substrates, which could be considered for\nsafety when designing pharmaceutical formulations.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874467215666220127121817","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T08:10:06Z","timestamp":1643357406000},"page":"987-995","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the Effect of Isobutyl Paraben and 2-ethyl Hexyl Paraben on\nP-glycoprotein Functional Expression in Rats: A Pharmacokinetic Study"],"prefix":"10.1016","volume":"15","author":[{"given":"Osama Y.","family":"Alshogran","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour F. Al","family":"Ghraiybah","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayer","family":"I. Al-Azzam","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1042\/bse0500161","volume":"50","author":"Sharom F.J.","year":"2011","unstructured":"Sharom F.J.; The P-glycoprotein multidrug transporter. Essays Biochem 2011,50(1),161-178","journal-title":"Essays Biochem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","volume":"22","author":"Ambudkar S.V.","year":"2003","unstructured":"Ambudkar S.V.; Kimchi-Sarfaty C.; Sauna Z.E.; Gottesman M.M.; P-glycoprotein: From genomics to mechanism. Oncogene 2003,22(47),7468-7485","journal-title":"Oncogene"},{"key":"ref=3","first-page":"3808","volume":"9","author":"Chin J.E.","year":"1989","unstructured":"Chin J.E.; Soffir R.; Noonan K.E.; Choi K.; Roninson I.B.; Structure and expression of the human MDR (P-glycoprotein) gene family. Mol Cell Biol 1989,9(9),3808-3820","journal-title":"Mol Cell Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","volume":"58","author":"Endicott J.A.","year":"1989","unstructured":"Endicott J.A.; Ling V.; The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989,58(1),137-171","journal-title":"Annu Rev Biochem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/38.9.1974900","volume":"38","author":"Cordon-Cardo C.","year":"1990","unstructured":"Cordon-Cardo C.; O\u2019Brien J.P.; Boccia J.; Casals D.; Bertino J.R.; Melamed M.R.; Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990,38(9),1277-1287","journal-title":"J Histochem Cytochem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1080\/00498250701867889","volume":"38","author":"Zhou S.F.","year":"2008","unstructured":"Zhou S.F.; Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008,38(7-8),802-832","journal-title":"Xenobiotica"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.reprotox.2006.01.007","volume":"22","author":"Ceckova-Novotna M.","year":"2006","unstructured":"Ceckova-Novotna M.; Pavek P.; Staud F.; P-glycoprotein in the placenta: Expression, localization, regulation and function. Reprod Toxicol 2006,22(3),400-410","journal-title":"Reprod Toxicol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1126\/science.1168750","volume":"323","author":"Aller S.G.","year":"2009","unstructured":"Aller S.G.; Yu J.; Ward A.; Weng Y.; Chittaboina S.; Zhuo R.; Harrell P.M.; Trinh Y.T.; Zhang Q.; Urbatsch I.L.; Chang G.; Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009,323(5922),1718-1722","journal-title":"Science"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1590\/S1984-82502012000300002","volume":"48","author":"Srivalli K.M.R.","year":"2012","unstructured":"Srivalli K.M.R.; Lakshmi P.K.; Overview of P-glycoprotein inhibitors: A rational outlook. Braz J Pharm Sci 2012,48,353-367","journal-title":"Braz J Pharm Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpharm.2004.03.001","volume":"278","author":"Cornaire G.","year":"2004","unstructured":"Cornaire G.; Woodley J.; Hermann P.; Cloarec A.; Arellano C.; Houin G.; Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 2004,278(1),119-131","journal-title":"Int J Pharm"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ijpharm.2018.04.006","volume":"543","author":"Al-Ali A.A.A.","year":"2018","unstructured":"Al-Ali A.A.A.; Quach J.R.C.; Bundgaard C.; Steffansen B.; Holm R.; Nielsen C.U.; Polysorbate 20 alters the oral bioavailability of etoposide in wild type and mdr1a deficient Sprague-Dawley rats. Int J Pharm 2018,543(1-2),352-360","journal-title":"Int J Pharm"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clpt.2004.09.001","volume":"77","author":"Bogman K.","year":"2005","unstructured":"Bogman K.; Zysset Y.; Degen L.; Hopfgartner G.; Gutmann H.; Alsenz J.; Drewe J.; P-glycoprotein and surfactants: Effect on intestinal talinolol absorption. Clin Pharmacol Ther 2005,77(1),24-32","journal-title":"Clin Pharmacol Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.fct.2011.12.045","volume":"50","author":"Aubert N.","year":"2012","unstructured":"Aubert N.; Ameller T.; Legrand J-J.; Systemic exposure to parabens: pharmacokinetics, tissue distribution, excretion balance and plasma metabolites of [14C]-methyl-, propyl- and butylparaben in rats after oral, topical or subcutaneous administration. Food Chem Toxicol 2012,50(3-4),445-454","journal-title":"Food Chem Toxicol"},{"year":"2018","author":"Tade R.","key":"ref=14","unstructured":"Tade R.; Safety and toxicity assessment of parabens in pharmaceutical and food products. 2018"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1289\/EHP3523","volume":"127","author":"Philippat C.","year":"2019","unstructured":"Philippat C.; Heude B.; Botton J.; Alfaidy N.; Calafat A.M.; Slama R.; Prenatal exposure to select phthalates and phenols and associations with fetal and placental weight among male births in the EDEN Cohort (France). Environ Health Perspect EDEN Mother-Child Cohort Study Group2019,127(1),17002","journal-title":"Environ Health Perspect"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.reprotox.2015.02.002","volume":"52","author":"Dodge L.E.","year":"2015","unstructured":"Dodge L.E.; Kelley K.E.; Williams P.L.; Williams M.A.; Hern\u00e1ndez-D\u00edaz S.; Missmer S.A.; Hauser R.; Medications as a source of paraben exposure. Reprod Toxicol 2015,52,93-100","journal-title":"Reprod Toxicol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.reprotox.2018.02.008","volume":"77","author":"Smarr M.M.","year":"2018","unstructured":"Smarr M.M.; Honda M.; Kannan K.; Chen Z.; Kim S.; Louis G.M.B.; Male urinary biomarkers of antimicrobial exposure and bi-directional associations with semen quality parameters. Reprod Toxicol 2018,77,103-108","journal-title":"Reprod Toxicol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2131\/jts.41.551","volume":"41","author":"Ozaki H.","year":"2016","unstructured":"Ozaki H.; Sugihara K.; Watanabe Y.; Ohta S.; Kitamura S.; Cytochrome P450-inhibitory activity of parabens and phthalates used in consumer products. J Toxicol Sci 2016,41(4),551-560","journal-title":"J Toxicol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1096\/fasebj.2019.33.1_supplement.814.3","volume":"33","author":"Bajaj R","year":"2019","unstructured":"Bajaj R; Chong LB; Zou L; Tsakalozou E; Ni Z; Giacomini K.M.; \nIn vitro evaluation of excipients as inhibitors of human intestinal P-glycoprotein. FASEB J 2019,33(S1),814","journal-title":"FASEB J"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.2042-7158.1987.tb03168.x","volume":"39","author":"Hinohara Y","year":"1987","unstructured":"Hinohara Y; Yamazaki T; Kuromaru O; Homma N; Sakai K; Effects of nicorandil and verapamil, antianginal agents, on plasma digoxin concentrations in rats and dogs. J Pharm Pharmacol 1987,39(7),512-526","journal-title":"J Pharm Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejps.2011.05.005","volume":"44","author":"Neerati P.","year":"2011","unstructured":"Neerati P.; Ganji D.; Bedada S.K.; Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats. Eur J Pharm Sci 2011,44(1-2),27-31","journal-title":"Eur J Pharm Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/BF02976689","volume":"26","author":"Zhang H.","year":"2003","unstructured":"Zhang H.; Yao M.; Morrison R.A.; Chong S.; Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch Pharm Res 2003,26(9),768-772","journal-title":"Arch Pharm Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Zhang Y.","year":"2010","unstructured":"Zhang Y.; Huo M.; Zhou J.; Xie S. PK.; Solver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 2010,99(3),306-314","journal-title":"Comput Methods Programs Biomed"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0731-7085(03)00050-5","volume":"32","author":"Yao M.","year":"2003","unstructured":"Yao M.; Zhang H.; Chong S.; Zhu M.; Morrison R.A.; A rapid and sensitive LC\/MS\/MS assay for quantitative determination of digoxin in rat plasma. J Pharm Biomed Anal 2003,32(6),1189-1197","journal-title":"J Pharm Biomed Anal"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/aps.2011.33","volume":"32","author":"Zhang L.L.","year":"2011","unstructured":"Zhang L.L.; Lu L.; Jin S.; Jing X.Y.; Yao D.; Hu N.; Liu L.; Duan R.; Liu X.D.; Wang G.J.; Xie L.; Tissue-specific alterations in expression and function of P-glycoprotein in streptozotocin-induced diabetic rats. Acta Pharmacol Sin 2011,32(7),956-966","journal-title":"Acta Pharmacol Sin"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.drudis.2009.07.010","volume":"14","author":"Bansal T.","year":"2009","unstructured":"Bansal T.; Akhtar N.; Jaggi M.; Khar R.K.; Talegaonkar S.; Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation. Drug Discov Today 2009,14(21-22),1067-1074","journal-title":"Drug Discov Today"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"8224","DOI":"10.3390\/ijms21218224","volume":"21","author":"Patel R","year":"2020","unstructured":"Patel R; Barker J; ElShaer A.; Pharmaceutical excipients and drug metabolism: A mini-review. 2020,21(21),8224"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0168-3659(03)00163-9","volume":"90","author":"Lo Y.L.","year":"2003","unstructured":"Lo Y.L.; Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J Control Release 2003,90(1),37-48","journal-title":"J Control Release"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijpharm.2016.09.011","volume":"513","author":"Nielsen C.U.","year":"2016","unstructured":"Nielsen C.U.; Abdulhussein A.A.; Colak D.; Holm R.; Polysorbate 20 increases oral absorption of digoxin in wild-type Sprague Dawley rats, but not in mdr1a(-\/-) Sprague Dawley rats. Int J Pharm 2016,513(1-2),78-87","journal-title":"Int J Pharm"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1172\/JCI118214","volume":"96","author":"Schinkel A.H.","year":"1995","unstructured":"Schinkel A.H.; Wagenaar E.; van Deemter L.; Mol C.A.; Borst P.; Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 1995,96(4),1698-1705","journal-title":"J Clin Invest"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcph.200","volume":"54","author":"Nader A.M.","year":"2014","unstructured":"Nader A.M.; Foster D.R.; Suitability of digoxin as a P-glycoprotein probe: implications of other transporters on sensitivity and specificity. J Clin Pharmacol 2014,54(1),3-13","journal-title":"J Clin Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0928-0987(01)00161-0","volume":"14","author":"Sababi M.","year":"2001","unstructured":"Sababi M.; Borg\u00e5 O.; Hultkvist-Bengtsson U.; The role of P-glycoprotein in limiting intestinal regional absorption of digoxin in rats. Eur J Pharm Sci 2001,14(1),21-27","journal-title":"Eur J Pharm Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.CIR.65.5.998","volume":"65","author":"Klein H.O.","year":"1982","unstructured":"Klein H.O.; Lang R.; Weiss E.; Di Segni E.; Libhaber C.; Guerrero J.; Kaplinsky E.; The influence of verapamil on serum digoxin concentration. Circulation 1982,65(5),998-1003","journal-title":"Circulation"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/clpt.1991.26","volume":"49","author":"Hedman A.","year":"1991","unstructured":"Hedman A.; Angelin B.; Arvidsson A.; Beck O.; Dahlqvist R.; Nilsson B.; Olsson M.; Schenck-Gustafsson K.; Digoxin-verapamil interaction: Reduction of biliary but not renal digoxin clearance in humans. Clin Pharmacol Ther 1991,49(3),256-262","journal-title":"Clin Pharmacol Ther"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0002-8703(85)90021-3","volume":"110","author":"Kuhlmann J.","year":"1985","unstructured":"Kuhlmann J.; Marcin S.; Effects of verapamil on pharmacokinetics and pharmacodynamics of digitoxin in patients. Am Heart J 1985,110(6),1245-1250","journal-title":"Am Heart J"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e17741-e","DOI":"10.17795\/jjnpp-17741","volume":"9","author":"Jalali A.","year":"2014","unstructured":"Jalali A.; Ghasemian S.; Najafzadeh H.; Galehdari H.; Seifi M.R.; Zangene F.; Verapamil and rifampin effect on p-glycoprotein expression in hepatocellular carcinoma. Jundishapur J Nat Pharm Prod 2014,9(4),e17741-e","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ijc.2910560523","volume":"56","author":"Muller C.","year":"1994","unstructured":"Muller C.; Bailly J-D.; Goubin F.; Laredo J.; Jaffr\u00e9zou J-P.; Bordier C.; Laurent G.; Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines. Int J Cancer 1994,56(5),749-754","journal-title":"Int J Cancer"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/jphp.12124","volume":"65","author":"Theile D.","year":"2013","unstructured":"Theile D.; Schmidt T.T.; Haefeli W.E.; Weiss J.; \nIn vitro evaluation of chronic alcohol effects on expression of drug-metabolizing and drug-transporting proteins. J Pharm Pharmacol 2013,65(10),1518-1525","journal-title":"J Pharm Pharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/1087057106295383","volume":"12","author":"Lakeram M.","year":"2007","unstructured":"Lakeram M.; Lockley D.J.; Sanders D.J.; Pendlington R.; Forbes B.; Paraben transport and metabolism in the biomimetic artificial membrane permeability assay (BAMPA) and 3-day and 21-day Caco-2 cell systems. J Biomol Screen 2007,12(1),84-91","journal-title":"J Biomol Screen"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/187231209788654081","volume":"3","author":"Berry L.M.","year":"2009","unstructured":"Berry L.M.; Wollenberg L.; Zhao Z.; Esterase activities in the blood, liver and intestine of several preclinical species and humans. Drug Metab Lett 2009,3(2),70-77","journal-title":"Drug Metab Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jpha.2012.01.007","volume":"2","author":"Tang Y-H.","year":"2012","unstructured":"Tang Y-H.; Wang J-Y.; Hu H-H.; Yao T-W.; Zeng S.; Analysis of species-dependent hydrolysis and protein binding of esmolol enantiomers. J Pharm Anal 2012,2(3),220-225","journal-title":"J Pharm Anal"},{"key":"ref=42","first-page":"788","volume":"76","author":"Hodaei D.","year":"2014","unstructured":"Hodaei D.; Baradaran B.; Valizadeh H.; Mohammadnejad L.; Zakeri P.; The effect of tween excipients on expression and activity of P-glycoprotein in Caco-2 cells. Pharm Ind 2014,76,788-794","journal-title":"Pharm Ind"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/0973-8398.154688","volume":"9","author":"Thakkar H.","year":"2015","unstructured":"Thakkar H.; Desai J.; Influence of excipients on drug absorption via modulation of intestinal transporters activity. Asian J Pharm 2015,9(2),69-82","journal-title":"Asian J Pharm"},{"key":"ref=44","first-page":"319","volume":"10","author":"Sachs-Barrable K","year":"2007","unstructured":"Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM; Lipid excipients Peceol and Gelucire 44\/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells. J Pharm Pharma Sci 2007,10(3),319-331","journal-title":"J Pharm Pharma Sci"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1874467215666220127121817","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200592\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1874467215666220127121817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:57:57Z","timestamp":1746572277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200592\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467215666220127121817","relation":{},"ISSN":["1874-4672"],"issn-type":[{"type":"print","value":"1874-4672"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}